Interventional Radiology Market Growth Analysis - Market Size, Share, Forecast Trends and Outlook Report (2025-2034)
Description
The global interventional radiology market size reached around USD 24.20 Billion in 2024. The market is projected to grow at a CAGR of 6.70% between 2025 and 2034 to reach nearly USD 46.29 Billion by 2034.
Global Interventional Radiology Market Overview
Interventional radiology (IR) refers to a collection of methods that direct medical imaging like x-ray fluoroscopy, magnetic resonance imaging, computed tomography, or ultrasound to guide medical therapies via very small incisions specifically towards the internal structure of the body. The interventional radiology market growth is driven by several factors including its expanded application across different domains like cardiology, musculoskeletal interventions, oncology, and neurology. The rising prevalence for minimally invasive procedures, along with patient centric approaches, personalized treatment plans and integration of artificial intelligence and robotics, also contribute to the rising market value.
New Product Launches to Meet the Rising Interventional Radiology Market Demand
In May 2023, United Imaging launched an entire range of products imaging and digital solutions, enabled with artificial intelligence capacity across multiple modalities. Some of the notable inventions include the uRT-linac 506c, a LINAC device that combines a diagnostic CT imager and a linear accelerator to offer continuous treatment simulation. Other cutting-edge solutions include PET/CT uEXPLORER®, the uMR® Jupiter 5.0T, uMI Panorama™, and the ultra-high-field preclinical 9.4T MR.
The interventional radiology market share is poised to grow further with multiple companies stepping up to unveil innovative and technology driven equipment. In September 2023, Canon Medical Systems Corporation introduced Alphenix Sky 12 HD interventional system that offers twice as much better resolution than the conventional flat panel detectors. With the new 12” × 12” high-definition (Hi-Def) detector, the system aims at offering improved interventional imaging efficiency for multiple domains, including neurology, cardiology, oncology, and pediatric care.
Surge in Investments to Offer Improved Solutions
In June 2023, Flow Medical , a University of Chicago startup, received a USD 1 million investment to develop and commercialize their latest multi-function catheter to help diagnose and treat venous thromboembolic disease. The funds are expected to expediate the device development and testing process so as to facilitate the submission for FDA 510(k) approval by the first quarter of 2025. The growth in investments for enhanced research activities in poised to boost the interventional radiology market growth in the forecast period.
Increasing Integration of Artificial Intelligence Based and Smart Solutions
The healthcare landscape is witnessing rising integration of smart and artificial intelligence run solutions. To offer improved patient and staff experience and drive operational efficiency at a lower cost of care, leading healthcare companies such as Royal Philips have started developing and applying smart connected imaging systems into relevant treatment plans. For instance, MR 5300 is an artificial intelligence run technology that automates several compound clinical and operational tasks to enhance clinical decision-making and speed up the imaging process. The rising application of latest technologies in the radiology scenario is likely to drive a significant upswing in the interventional radiology market size.
In addition, the advent of Phillips MR 7700 in 3.0T imaging is a breakthrough as it facilitates an enhanced gradient system for better imaging results. Along with an improved image quality, it has reduced the scan time by 35% enabling and allows imaging six different nuclei at the same time, which has been a major help for radiologists.
Global Interventional Radiology Market Segmentation
Market Breakup by Products
The United States is anticipated to lead the global market owing to the presence of prominent healthcare companies. The presence of a robust healthcare infrastructure aids the market share as well. The region is witnessing continuous infrastructure related developments. In October 2023, Children’s Hospital Los Angeles opened a new interventional radiology suite with latest technology aimed at improving patient care. This hospital is likely to contribute significantly to the rising interventional radiology market share in the coming years.
The new diagnostic facility for children includes state-of-the-art machinery that combines fluoroscopy and CT scanning. It also includes a biplane angiography machine to allow radiologists to make videos during X-ray procedures. The opening of such facilities is expected to improve the accessibility for advanced imaging alternatives, ensuring quality care and patient safety.
Global Interventional Radiology Market: Competitor Landscape
In January 2023, GE Healthcare acquired Imactis, a French CT interventional guidance technology to strengthen their imaging technology portfolio by leveraging the IMACTIS CT-Navigation system. An ergonomic universal solution, CT-Navigation™ offers stereotactic needle guidance for continuous and pre-planned control across several diagnostics to treatments. With this acquisition, GE has showed the intent of expanding their technologies into image guided therapies business to maximize growth.
The key features of the interventional radiology market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Global Interventional Radiology Market Overview
Interventional radiology (IR) refers to a collection of methods that direct medical imaging like x-ray fluoroscopy, magnetic resonance imaging, computed tomography, or ultrasound to guide medical therapies via very small incisions specifically towards the internal structure of the body. The interventional radiology market growth is driven by several factors including its expanded application across different domains like cardiology, musculoskeletal interventions, oncology, and neurology. The rising prevalence for minimally invasive procedures, along with patient centric approaches, personalized treatment plans and integration of artificial intelligence and robotics, also contribute to the rising market value.
New Product Launches to Meet the Rising Interventional Radiology Market Demand
In May 2023, United Imaging launched an entire range of products imaging and digital solutions, enabled with artificial intelligence capacity across multiple modalities. Some of the notable inventions include the uRT-linac 506c, a LINAC device that combines a diagnostic CT imager and a linear accelerator to offer continuous treatment simulation. Other cutting-edge solutions include PET/CT uEXPLORER®, the uMR® Jupiter 5.0T, uMI Panorama™, and the ultra-high-field preclinical 9.4T MR.
The interventional radiology market share is poised to grow further with multiple companies stepping up to unveil innovative and technology driven equipment. In September 2023, Canon Medical Systems Corporation introduced Alphenix Sky 12 HD interventional system that offers twice as much better resolution than the conventional flat panel detectors. With the new 12” × 12” high-definition (Hi-Def) detector, the system aims at offering improved interventional imaging efficiency for multiple domains, including neurology, cardiology, oncology, and pediatric care.
Surge in Investments to Offer Improved Solutions
In June 2023, Flow Medical , a University of Chicago startup, received a USD 1 million investment to develop and commercialize their latest multi-function catheter to help diagnose and treat venous thromboembolic disease. The funds are expected to expediate the device development and testing process so as to facilitate the submission for FDA 510(k) approval by the first quarter of 2025. The growth in investments for enhanced research activities in poised to boost the interventional radiology market growth in the forecast period.
Increasing Integration of Artificial Intelligence Based and Smart Solutions
The healthcare landscape is witnessing rising integration of smart and artificial intelligence run solutions. To offer improved patient and staff experience and drive operational efficiency at a lower cost of care, leading healthcare companies such as Royal Philips have started developing and applying smart connected imaging systems into relevant treatment plans. For instance, MR 5300 is an artificial intelligence run technology that automates several compound clinical and operational tasks to enhance clinical decision-making and speed up the imaging process. The rising application of latest technologies in the radiology scenario is likely to drive a significant upswing in the interventional radiology market size.
In addition, the advent of Phillips MR 7700 in 3.0T imaging is a breakthrough as it facilitates an enhanced gradient system for better imaging results. Along with an improved image quality, it has reduced the scan time by 35% enabling and allows imaging six different nuclei at the same time, which has been a major help for radiologists.
Global Interventional Radiology Market Segmentation
Market Breakup by Products
- MRI Systems
- CT Scanners
- Ultrasound Imaging Systems
- Angiography Systems
- Biopsy Devices
- Fluoroscopy Systems
- Others
- Catheters
- Stents
- Inferior Vena Cava (IVC) Filters
- Hemodynamic Flow Alteration (HFA) Devices
- Angioplasty Balloons
- Thrombectomy Systems
- Embolization Devices
- Biopsy Needles
- Accessories
- Others
- Angioplasty
- Angiography
- Embolization
- Thrombolysis
- Biopsy and Drainage
- Vertebroplasty
- Nephrostomy
- Other Procedures
- Cardiology
- Urology and Nephrology
- Oncology
- Gastroenterology
- Obstetrics
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The United States is anticipated to lead the global market owing to the presence of prominent healthcare companies. The presence of a robust healthcare infrastructure aids the market share as well. The region is witnessing continuous infrastructure related developments. In October 2023, Children’s Hospital Los Angeles opened a new interventional radiology suite with latest technology aimed at improving patient care. This hospital is likely to contribute significantly to the rising interventional radiology market share in the coming years.
The new diagnostic facility for children includes state-of-the-art machinery that combines fluoroscopy and CT scanning. It also includes a biplane angiography machine to allow radiologists to make videos during X-ray procedures. The opening of such facilities is expected to improve the accessibility for advanced imaging alternatives, ensuring quality care and patient safety.
Global Interventional Radiology Market: Competitor Landscape
In January 2023, GE Healthcare acquired Imactis, a French CT interventional guidance technology to strengthen their imaging technology portfolio by leveraging the IMACTIS CT-Navigation system. An ergonomic universal solution, CT-Navigation™ offers stereotactic needle guidance for continuous and pre-planned control across several diagnostics to treatments. With this acquisition, GE has showed the intent of expanding their technologies into image guided therapies business to maximize growth.
The key features of the interventional radiology market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- General Electric
- Koninklijke Philips N.V.
- Carestream Health
- Hitachi, Ltd.
- Hologic, Inc.
- Shimadzu Corporation
- Siemens Healthcare GmbH
- Canon Medical Systems Corporation
- Samsung Medison Co., Ltd.
- Medtronic Plc
- Agfa-Gevaert Group
- Teleflex Incorporated
- Analogic Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Trivitron Healthcare
- Stryker Corporation
- Olympus Corporation
- Toshiba Medical Systems
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Interventional Radiology Market Overview
- 3.1 Global Interventional Radiology Market Historical Value (2018-2024)
- 3.2 Global Interventional Radiology Market Forecast Value (2025-2034)
- 4 Global Interventional Radiology Market Landscape*
- 4.1 Global Interventional Radiology: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Interventional Radiology: Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Applications
- 5 Global Interventional Radiology Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Interventional Radiology Market Segmentation (218-2034)
- 6.1 Global Interventional Radiology Market (2018-2034) by Products
- 6.1.1 Market Overview
- 6.1.2 MRI Systems
- 6.1.3 CT Scanners
- 6.1.4 Ultrasound Imaging Systems
- 6.1.5 Angiography Systems
- 6.1.6 Biopsy Devices
- 6.1.7 Fluoroscopy Systems
- 6.1.8 Others
- 6.2 Global Interventional Radiology Market (2018-2034) by Technology
- 6.2.1 Market Overview
- 6.2.2 Catheters
- 6.2.3 Stents
- 6.2.4 Inferior Vena Cava (IVC) Filters
- 6.2.5 Hemodynamic Flow Alteration (HFA) Devices
- 6.2.6 Angioplasty Balloons
- 6.2.7 Thrombectomy Systems
- 6.2.8 Embolization Devices
- 6.2.9 Biopsy Needles
- 6.2.10 Accessories
- 6.2.11 Others
- 6.3 Global Interventional Radiology Market (2018-2034) by Procedure
- 6.3.1 Market Overview
- 6.3.2 Angioplasty
- 6.3.3 Angiography
- 6.3.4 Embolization
- 6.3.5 Thrombolysis
- 6.3.6 Biopsy and Drainage
- 6.3.7 Vertebroplasty
- 6.3.8 Nephrostomy
- 6.3.9 Other Procedures
- 6.4 Global Interventional Radiology Market (2018-2034) by Application
- 6.4.1 Market Overview
- 6.4.2 Cardiology
- 6.4.3 Urology and Nephrology
- 6.4.4 Oncology
- 6.4.5 Gastroenterology
- 6.4.6 Obstetrics
- 6.4.7 Others
- 6.5 Global Interventional Radiology Market (2018-2034) by End User
- 6.5.1 Market Overview
- 6.5.2 Hospitals
- 6.5.3 Clinics
- 6.5.4 Ambulatory Surgical Centres
- 6.5.5 Others
- 6.6 Global Interventional Radiology Market (2018-2034) by Region
- 6.6.1 Market Overview
- 6.6.2 North America
- 6.6.3 Europe
- 6.6.4 Asia Pacific
- 6.6.5 Latin America
- 6.6.6 Middle East and Africa
- 7 North America Interventional Radiology Market (218-2034)
- 7.1 North America Interventional Radiology Market (2018-2034) by Products
- 7.1.1 Market Overview
- 7.1.2 MRI Systems
- 7.1.3 CT Scanners
- 7.1.4 Ultrasound Imaging Systems
- 7.1.5 Angiography Systems
- 7.1.6 Biopsy Devices
- 7.1.7 Fluoroscopy Systems
- 7.1.8 Others
- 7.2 North America Interventional Radiology Market (2018-2034) by Procedure
- 7.2.1 Market Overview
- 7.2.2 Angioplasty
- 7.2.3 Angiography
- 7.2.4 Embolization
- 7.2.5 Thrombolysis
- 7.2.6 Biopsy and Drainage
- 7.2.7 Vertebroplasty
- 7.2.8 Nephrostomy
- 7.2.9 Other Procedures
- 7.3 North America Interventional Radiology Market (2018-2034) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Interventional Radiology Market (218-2034)
- 8.1 Europe Interventional Radiology Market (2018-2034) by Products
- 8.1.1 Market Overview
- 8.1.2 MRI Systems
- 8.1.3 CT Scanners
- 8.1.4 Ultrasound Imaging Systems
- 8.1.5 Angiography Systems
- 8.1.6 Biopsy Devices
- 8.1.7 Fluoroscopy Systems
- 8.1.8 Others
- 8.2 Europe Interventional Radiology Market (2018-2034) by Procedure
- 8.2.1 Market Overview
- 8.2.2 Angioplasty
- 8.2.3 Angiography
- 8.2.4 Embolization
- 8.2.5 Thrombolysis
- 8.2.6 Biopsy and Drainage
- 8.2.7 Vertebroplasty
- 8.2.8 Nephrostomy
- 8.2.9 Other Procedures
- 8.3 Europe Interventional Radiology Market (2018-2034) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Interventional Radiology Market (218-2034)
- 9.1 Asia Pacific Interventional Radiology Market (2018-2034) by Products
- 9.1.1 Market Overview
- 9.1.2 MRI Systems
- 9.1.3 CT Scanners
- 9.1.4 Ultrasound Imaging Systems
- 9.1.5 Angiography Systems
- 9.1.6 Biopsy Devices
- 9.1.7 Fluoroscopy Systems
- 9.1.8 Others
- 9.2 Asia Pacific Interventional Radiology Market (2018-2034) by Procedure
- 9.2.1 Market Overview
- 9.2.2 Angioplasty
- 9.2.3 Angiography
- 9.2.4 Embolization
- 9.2.5 Thrombolysis
- 9.2.6 Biopsy and Drainage
- 9.2.7 Vertebroplasty
- 9.2.8 Nephrostomy
- 9.2.9 Other Procedures
- 9.3 Asia Pacific Interventional Radiology Market (2018-2034) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 ASEAN
- 9.3.5 Australia
- 9.3.6 Others
- 10 Latin America Interventional Radiology Market (218-2034)
- 10.1 Latin America Interventional Radiology Market (2018-2034) by Products
- 10.1.1 Market Overview
- 10.1.2 MRI Systems
- 10.1.3 CT Scanners
- 10.1.4 Ultrasound Imaging Systems
- 10.1.5 Angiography Systems
- 10.1.6 Biopsy Devices
- 10.1.7 Fluoroscopy Systems
- 10.1.8 Others
- 10.2 Latin America Interventional Radiology Market (2018-2034) by Procedure
- 10.2.1 Market Overview
- 10.2.2 Angioplasty
- 10.2.3 Angiography
- 10.2.4 Embolization
- 10.2.5 Thrombolysis
- 10.2.6 Biopsy and Drainage
- 10.2.7 Vertebroplasty
- 10.2.8 Nephrostomy
- 10.2.9 Other Procedures
- 10.3 Latin America Interventional Radiology Market (2018-2034) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Interventional Radiology Market (218-2034)
- 11.1 Middle East and Africa Interventional Radiology Market (2018-2034) by Products
- 11.1.1 Market Overview
- 11.1.2 MRI Systems
- 11.1.3 CT Scanners
- 11.1.4 Ultrasound Imaging Systems
- 11.1.5 Angiography Systems
- 11.1.6 Biopsy Devices
- 11.1.7 Fluoroscopy Systems
- 11.1.8 Others
- 11.2 Middle East and Africa Interventional Radiology Market (2018-2034) by Procedure
- 11.2.1 Market Overview
- 11.2.2 Angioplasty
- 11.2.3 Angiography
- 11.2.4 Embolization
- 11.2.5 Thrombolysis
- 11.2.6 Biopsy and Drainage
- 11.2.7 Vertebroplasty
- 11.2.8 Nephrostomy
- 11.2.9 Other Procedures
- 11.3 Middle East and Africa Interventional Radiology Market (2018-2034) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 General Electric
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Koninklijke Philips N.V.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Carestream Health
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Hitachi, Ltd.
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Hologic, Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Shimadzu Corporation
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Siemens Healthcare GmbH
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Canon Medical Systems Corporation
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Samsung Medison Co., Ltd.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Medtronic Plc
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Agfa-Gevaert Group
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Teleflex Incorporated
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Analogic Corporation
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Trivitron Healthcare
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 17.16 Stryker Corporation
- 17.16.1 Financial Analysis
- 17.16.2 Product Portfolio
- 17.16.3 Demographic Reach and Achievements
- 17.16.4 Mergers and Acquisitions
- 17.16.5 Certifications
- 17.17 Olympus Corporation
- 17.17.1 Financial Analysis
- 17.17.2 Product Portfolio
- 17.17.3 Demographic Reach and Achievements
- 17.17.4 Mergers and Acquisitions
- 17.17.5 Certifications
- 17.18 Toshiba Medical Systems
- 17.18.1 Financial Analysis
- 17.18.2 Product Portfolio
- 17.18.3 Demographic Reach and Achievements
- 17.18.4 Mergers and Acquisitions
- 17.18.5 Certifications
- 18 Global Interventional Radiology Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
